Item(by='dm319', descendants=None, kids=None, score=None, time=1607882315, title=None, item_type='comment', url=None, parent=25408379, text='What is particularly interesting is the response in the elderly population, as it&#x27;s this group that seem most at-risk.  The earlier studies were done in a younger population without co-morbidities, but later studies included all-comers.  The pfizer study included older patients, though not many by the looks of it.  They allowed for those with chronic conditions, though not if they were immunocompromised as a result of it.  9% black&#x2F;african-american and 28% hispanic.')